
Sign up to save your podcasts
Or


In this episode, we discuss whether early nonresponse in adolescents with first-episode psychosis predicts longer-term nonresponse and nonremission. We also explain when it is most likely that symptom improvement occurs and some other considerations when there is nonresponse.
Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.
By Psychopharmacology Institute4.6
268268 ratings
In this episode, we discuss whether early nonresponse in adolescents with first-episode psychosis predicts longer-term nonresponse and nonremission. We also explain when it is most likely that symptom improvement occurs and some other considerations when there is nonresponse.
Faculty: David Rosenberg, M.D. Host: Richard Seeber, M.D.

75 Listeners

147 Listeners

263 Listeners

3,338 Listeners

158 Listeners

562 Listeners

1,348 Listeners

714 Listeners

240 Listeners

564 Listeners

17 Listeners

471 Listeners

724 Listeners

190 Listeners

139 Listeners